51 million adults (20-79) are living with diabetes in the IDF North America and Caribbean Region in 2021. This figure is estimated to increase to 57million by 2030 and 63 million by 2045.
12 million adults living with diabetes in the IDF North America and Caribbean Region are undiagnosed - 24% of the total number of adults living with diabetes in the region.
47 million adults (20-79) in the IDF North America and Caribbean Region have Impaired Glucose Tolerance (IGT), which places them at high risk of developing type 2 diabetes. This number is expected to reach 52 million by 2030 and 57 million by 2045.
USD 415 billion was spent on healthcare for people with diabetes in 2021. This amounts to 43% of global diabetes-related health expenditure.
1 in 6 live births in the IDF North America and Caribbean Region are affected by hyperglycaemia in pregnancy.